3 months or so ago.. I wud have agreed, but I'm not so sure anymore... it kinda seems like this is stuck in the 20-22 range... every big gain day has retraced... I hope this is just a bump on the road... but if ur holding thru earnings... it doesnt even matter where its at going into earnings... it will come out of earnings relatively the same price... whether it goes into it 22, or 25....( depending on the results)
Reality and execution of business model now have to catch up to price. If they pull off 1.00 plus in earnings this should be 30.00 by year end. That doesn't even count the 100-450 million settlement with Par Pharmaceutical for infringing on Zegerid patents. How well they invest that money should also help the share price.
June 3rd slide show Uceris script increased 63 from 10 May 2013 to 17May 2013 if they could hold that pace for remaining weeks in 2nd Q SNTS should be doing 1309 scripts a week by now. Go SNTS ! Some on this board have suggested script is 1800.00 that would be 2,356,200 a week in revenue just from this one drug and growing.